Metabolic management of ischaemic heart disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 7904560.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The present review summarizes the available information on the effects of the three major classes of antianginal agents (nitrates, calcium and beta-blockers) on myocardial energy metabolism. It also discusses the role of some new molecules (L-carnitine, trimetazidine and ranolazine) that have been proposed as an alternative pharmacological approach for the metabolic management of cardiac ischaemic syndromes.
Medical subject headings
- Adrenergic beta-Antagonists
- Angina Pectoris
- Calcium Channel Blockers
- Myocardium
- Nitroglycerin